ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Triumph Financial Inc

Triumph Financial Inc (TFIN)

77.16
1.20
( 1.58% )
Actualizado: 12:02:05

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
77.16
Postura de Compra
77.00
Postura de Venta
77.29
Volume Operado de la Acción
36,700
75.03 Rango del Día 77.46
66.85 Rango de 52 semanas 110.58
Capitalización de Mercado [m]
Precio Anterior
75.96
Precio de Apertura
75.74
Última hora de negociación
12:03:25
Volumen financiero
US$ 2,797,326
Precio Promedio Ponderado
76.2214
Volumen promedio (3 m)
122,639
Acciones en circulación
23,387,463
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
36.27
Beneficio por acción (BPA)
1.62
turnover
418.25M
Beneficio neto
37.88M

Acerca de Triumph Financial Inc

Triumph Financial Inc is a is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Corporate. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue de... Triumph Financial Inc is a is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Corporate. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit, and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The corporate segment includes holding company financing and investment activities and management and administrative expenses to support the overall operations of the Company. Mostrar más

Sector
State Commercial Banks
Industria
State Commercial Banks
Sede
Dallas, Texas, USA
Fundado
-
Triumph Financial Inc is listed in the State Commercial Banks sector of the NASDAQ with ticker TFIN. The last closing price for Triumph Financial was US$75.96. Over the last year, Triumph Financial shares have traded in a share price range of US$ 66.85 to US$ 110.58.

Triumph Financial currently has 23,387,463 shares in issue. The market capitalisation of Triumph Financial is US$1.78 billion. Triumph Financial has a price to earnings ratio (PE ratio) of 36.27.

TFIN Últimas noticias

Triumph Financial Releases Fourth Quarter 2024 Financial Results

DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its fourth quarter 2024 financial results. The 4Q 2024 financial results and shareholder letter are...

Triumph Financial Announces Schedule for Fourth Quarter 2024 Earnings Release and Conference Call

DALLAS, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its fourth quarter financial results and management commentary after...

Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock

DALLAS, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (the “Company”) (Nasdaq: TFIN) today announced that the Company’s Board of Directors declared a quarterly cash dividend of...

Triumph Financial to Present at the Stephens Annual Investment Conference on November 19, in Nashville, Tennessee

DALLAS, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that Aaron Graft, Vice Chairman and CEO, will present at the Stephens Annual Investment...

Triumph Financial Releases Third Quarter 2024 Financial Results

DALLAS, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) has released its third quarter 2024 financial results. The 3Q 2024 financial results and shareholder letter are...

Triumph Financial Announces Schedule for Third Quarter 2024 Earnings Release and Conference Call

DALLAS, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its third quarter financial results and management commentary after...

Ascent Global Logistics Joins the TriumphPay Network to Enhance Carrier Payments

DALLAS, Sept. 24, 2024 (GLOBE NEWSWIRE) -- TriumphPay announced today the addition of Ascent Global Logistics ("Ascent"), a leading global provider of expedited, time-critical logistics...

Triumph Financial Announces Dividend for 7.125% Series C Fixed-Rate Non-Cumulative Perpetual Preferred Stock

DALLAS, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (the “Company”) (Nasdaq: TFIN) today announced that the Company’s Board of Directors declared a quarterly cash dividend of...

ArcBest Joins the TriumphPay Network to Enhance Carrier Payments

DALLAS, Aug. 06, 2024 (GLOBE NEWSWIRE) -- TriumphPay announced today the addition of ArcBest® (Nasdaq: ARCB), a multibillion-dollar integrated logistics company offering one of the largest...

Triumph Financial Appoints Mitchell Lee as Chief Risk & Compliance Officer

DALLAS, July 30, 2024 (GLOBE NEWSWIRE) -- Triumph Financial, Inc. (Nasdaq: TFIN) is pleased to announce today the appointment of Mitchell Lee as chief risk and compliance officer. In his new...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
11.011.3263296126176.1579.8674.6511439177.23550353CS
4-10.86-12.338104976188.0292.43574.6512670483.71424626CS
12-22.8-22.809123649599.96110.5874.6512263993.9919644CS
26-2.65-3.3203859165579.81110.5873.4912968687.98616444CS
527.0510.055626872170.11110.5866.8515113081.82047333CS
15676.96439267.34693880.196110.580.19611601069.8737938CS
26076.96439267.34693880.196110.580.1967997069.8737938CS

TFIN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Triumph Financial?
El precio actual de las acciones de Triumph Financial es US$ 77.16
¿Cuántas acciones de Triumph Financial están en circulación?
Triumph Financial tiene 23,387,463 acciones en circulación
¿Cuál es la capitalización de mercado de Triumph Financial?
La capitalización de mercado de Triumph Financial es USD 1.78B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Triumph Financial?
Triumph Financial ha negociado en un rango de US$ 66.85 a US$ 110.58 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Triumph Financial?
El ratio precio/beneficio de Triumph Financial es 36.27
¿Cuál es el ratio de efectivo a ventas de Triumph Financial?
El ratio de efectivo a ventas de Triumph Financial es 3.28
¿Cuál es la moneda de reporte de Triumph Financial?
Triumph Financial presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Triumph Financial?
El último ingresos anual de Triumph Financial es USD 418.25M
¿Cuál es el último beneficio anual de Triumph Financial?
El último beneficio anual de Triumph Financial es USD 37.88M
¿Cuál es la dirección registrada de Triumph Financial?
La dirección registrada de Triumph Financial es 12700 PARK CENTRAL DRIVE, SUITE 1700, DALLAS, TEXAS, 75251
¿Cuál es la dirección del sitio web de Triumph Financial?
La dirección del sitio web de Triumph Financial es www.triumphbancorp.com
¿En qué sector industrial opera Triumph Financial?
Triumph Financial opera en el sector STATE COMMERCIAL BANKS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
CAPTCaptiVision Inc
US$ 1.3499
(207.49%)
199.79M
LTRYLottery com Inc
US$ 0.5649
(81.06%)
76.84M
QNTMQuantum Biopharma Ltd
US$ 5.1505
(61.97%)
47.81M
NVVENuvve Holding Corporation
US$ 3.90
(47.17%)
1.9M
PTIRGraniteShares 2X Long PLTR Daily ETF
US$ 218.6154
(40.76%)
1.49M
OMGAOmega Therapeutics Inc
US$ 0.22995
(-52.00%)
3.8M
UPCUniverse Pharmaceuticals Inc
US$ 0.2817
(-32.51%)
1.4M
CSAICloudastructure Inc
US$ 13.05
(-31.32%)
30.45k
VIRXViracta Therapeutics Inc
US$ 0.0539
(-30.72%)
4.64M
CYNCYNGN Inc
US$ 0.0835
(-28.57%)
55.05M
CAPTCaptiVision Inc
US$ 1.3499
(207.49%)
199.79M
PLTRPalantir Technologies Inc
US$ 100.72
(20.28%)
166.76M
NVDANVIDIA Corporation
US$ 118.51
(1.59%)
149.08M
RGTIRigetti Computing Inc
US$ 13.6418
(1.28%)
124.61M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.15805
(-18.91%)
95.04M
glenn1919 glenn1919 3 minutos hace
ltry.......................................https://stockcharts.com/h-sc/ui?s=LTRY&p=W&b=5&g=0&id=p86431144783
LTRY
AugustaFriends AugustaFriends 3 minutos hace
$LTRY joined you at .52xxx -- hope for AFTER HOURS runner
LTRY
Rum_Tequila Rum_Tequila 3 minutos hace
re: refine the protocols

so if you are the patient and your doctor tells you “80% reduced” you are thrilled and you reply, “great, let’s hit it one more time” Right?
RDGL
NoScaredMoneyHere NoScaredMoneyHere 3 minutos hace
That thought, at this stage even if management says that they have nothing to update XYZ are all still in play/ developing it still would be better than this abyss we stare in daily 🤷🏽‍♂️
XYZ
chsmoke chsmoke 3 minutos hace
srinsocal.
drop the sp? it's .0002!
what is a person like you holding onto here?
I own many millions of shares. have since 2012. average price, .0017.
I do not believe we will ever hear anything more from Biel except maybe Kelly posting something self-serving
on
BIEL
dheminger dheminger 4 minutos hace
Ok 👍 sorry bro
flipper44 flipper44 4 minutos hace
I’m sorry, I’m busy reading muee’s last two posts over and over.
NWBO
KRISGO KRISGO 4 minutos hace
"Julian Beach, MHRA Executive Director of Healthcare Quality and Access said:
“Individualised cancer immunotherapies, while still being tested in clinical trials, are a very exciting development in our hunt to find new and better ways to treat cancer, which is a leading cause of death worldwi
NWBO
DrHigh DrHigh 4 minutos hace
Thanks for reaching out to them and sharing their response.
NWBO
Gobsmacked01 Gobsmacked01 4 minutos hace
Imagine thinking you can compete with our 80% reduction stat when your product simply offers replacing a tumor lump infringing on vocal chords with a lump of glass marbles glued together of similar size n inconvenience... no comparison, really, imho.

-Go $RDGL
RDGL
LongCA LongCA 4 minutos hace
Chart looking fine here. $TMMI
Deep reset after the resent move, but it need to take a break.
Accum up, MACD turning back up ...

[url=https://postimg.cc/ygr2tMg0]https://i.postimg.cc/cCsZgZdk/Capture.png
TMMI
MDA MDA 4 minutos hace
Facts matter, nothing but RED volume bars too
HCMC
StockDetective StockDetective 4 minutos hace
https://www.credexcorporation.com/CREDEX%20CORPORATION--Letter%20from%20Investor%20Relations%2001.31.2025.pdf
AMMJ
Monksdream Monksdream 4 minutos hace
HIMS (own it)/new 52/high
https://investorshub.advfn.com/uimage/uploads/2025/2/4/pdiaxIMG_4991.gif
Triple nickle Triple nickle 5 minutos hace
Stated ltry 
BlazingStocks BlazingStocks 5 minutos hace
$COEP - With the establishment of our new Technology Division, COEPTIS aims to enhance operational capabilities and maximize shareholder value. Central to this initiative was the recent acquisition of the NexGenAI Affiliates Network platform, a groundbreaking AI-powered marketing solution. This acqu
COEP
Trooperstocks Trooperstocks 5 minutos hace
$COEP Article: Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation https://finance.yahoo.com/news/coeptis-therapeutics-holdings-inc-coep-151215721.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
@coeptistx

@Nasdaq
COEP
Trooperstocks Trooperstocks 5 minutos hace
$COEP Article: Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation https://finance.yahoo.com/news/coeptis-therapeutics-holdings-inc-coep-151215721.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
@coeptistx

@Nasdaq
COEP
Candid One Candid One 5 minutos hace
The silence of bankruptcy is in stark contrast to
Thriving corporations . There’s nothing here . This corporation is dead . Hellooooo just the same .
IAHL
Top Penny Top Penny 5 minutos hace
Let's rock!!!
PSRU
quester614 quester614 5 minutos hace
I admitted it was audited and found in financials on F-4. BTW that's what the F stands for. If the page is not in that group then auditor had nothing to do with what XERI said the R&D was used for. Hence the nondescript R&D instead of investment in XTI JV
quester614

Re: quester
XERI
johnydollar johnydollar 5 minutos hace
That sounds like a lot of teeth 😬 😳 gnashing going on.......

All those were bets on NEVERS.........


Oh well..........
DBMM
AugustaFriends AugustaFriends 5 minutos hace
which ticker

Su Consulta Reciente